Pyrazolopyrimidine compounds and their use as PDE10 inhibitors

Details for Australian Patent Application No. 2011221075 (hide)

Owner Mitsubishi Tanabe Pharma Corporation

Inventors Kawanishi, Eiji; Hongu, Mitsuya; Tanaka, Yoshihito

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011221075

PCT Pub. Number WO2011/105628

Priority 61/308,706 26.02.10 US

Filing date 25 February 2011

Wipo publication date 1 September 2011

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61K 31/5377

A61P 25/18 Drugs for disorders of the nervous system

A61P 25/22 Drugs for disorders of the nervous system

A61P 25/28 Drugs for disorders of the nervous system

A61P 25/30 Drugs for disorders of the nervous system

A61P 43/00 Drugs for specific purposes, not provided for in groups

Event Publications

6 September 2012 PCT application entered the National Phase

  PCT publication WO2011/105628 Priority application(s): WO2011/105628

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011221123-CO shift catalyst , CO shift reaction apparatus, and method for purification of gasified gas

2011221047-Heat-treated steel material, method for producing same, and base steel material for same